# Compare S-1 for 6 Months to 1 Year as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Staged II , IIIA or IIIB.

> **NCT02736552** · PHASE3 · WITHDRAWN · sponsor: **Fudan University**

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** S-1 for 6 months
- **DRUG:** S-1 for 1 year

## Key facts

- **NCT ID:** NCT02736552
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-03
- **Primary completion:** 2019-03
- **Final completion:** 2023-03
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2019-05-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02736552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02736552, "Compare S-1 for 6 Months to 1 Year as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Staged II , IIIA or IIIB.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02736552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*